Evaluation of HIV Non-occupational Post-exposure Prophylaxis Utilisation in a Tertiary Health Facility in Nigeria

  • Olanrewaju Fatai Olatunde Department of Dermatology/Venereology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
  • Oripelaye Muphy Mufutau Department of Dermatology/Venereology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
  • Ajani Atinuke Arinola Department of Dermatology/Venereology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
  • Enitan Ademola Olusegun Department of Dermatology/Venereology, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
Keywords: Evaluation, non-occupational, postexposure prophylaxis, HIV, utilisation

Abstract

Background

The Sub-Saharan Africa accounts for more than 70% of the global burden of HIV infections. Non-occupational post-exposure prophylaxis, when initiated within 72 hours of HIV exposure for 28 days, can prevent seroconversion in 80% of HIV exposures.

Objectives

To evaluate the characteristics, prevalence and outcome of non-occupational HIV post-exposure prophylaxis utilization in a tertiary hospital.

Method

This was a retrospective study that involved the medical records of 143 patients who sought HIV non-occupational post-exposure prophylaxis between 1st June 2011 and 31st May 2021. A questionnaire was used to collect information about the socio-demographic data, profiles of both the source and exposed persons, antiretroviral completion rate and outcome at follow-up.

Results

Females accounted for 125 (87.4%). Sexual assaults were the main reasons for seeking non-occupational post-exposure prophylaxis in 119 (83.2%). High-risk exposures were observed in 134 (93.7%). HIV status of the sources was unknown in 126 (88.1%). 123 (86.0%) initiated antiretroviral within 72 hours of exposure and antiretroviral completion rate was 70.6%. Only 28 (19.6%) reported for follow-up scheduled HIV screening and were all negative.

Conclusion

Early initiation of postexposure prophylaxis, improvement in baseline HIV testing of the source, and follow-up HIV screening, will significantly improve services and outcomes.

Rwanda J Med Health Sci 2022;5(3):264-275

Published
2022-12-20
Section
Articles

Journal Identifiers


eISSN: 2616-9827
print ISSN: 2616-9819